NCT02350036View on ClinicalTrials.gov

Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Preeclampsia
Interventions
OTHER

ultrasound monitoring

Uterine artery Doppler assessment

Trial Locations (1)

12151

Kasr Alainy medical school, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02350036 - Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia | Biotech Hunter | Biotech Hunter